SCHEMBL7963389

SCHEMBL7963389

Cc1cc(/C=C(/C#N)S(=O)(=O)Cc2cccc(C(F)(F)F)c2)cc(C)c1O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ ALOX5 P09917 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ GALR3 O60755 1/20 0.37
▸ AR P10275 1/20 0.37
▸ AKR1B1 P15121 1/20 0.36
▸ ACP3 P15309 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.36
▸ ERBB2 P04626 2/20 0.35
▸ EGFR P00533 2/20 0.35
▸ MAOB P27338 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963391 1.00 LMNA (0.38) LMNAGAABRD4ALOX5MAPT
SCHEMBL7963384 1.00 LMNA (0.38) LMNAGAABRD4ALOX5MAPT
SCHEMBL7964107 0.88 MAPT (0.43) LMNAGAAALOX5MAPTGALR3
SCHEMBL7964113 0.88 MAPT (0.43) LMNAGAAALOX5MAPTGALR3
SCHEMBL7964110 0.88 MAPT (0.43) LMNAGAAALOX5MAPTGALR3
SCHEMBL7964275 0.87 MAPT (0.42) LMNAGAAALOX5MAPTGALR3
SCHEMBL7964269 0.87 MAPT (0.42) LMNAGAAALOX5MAPTGALR3
SCHEMBL7964271 0.87 MAPT (0.42) LMNAGAAALOX5MAPTGALR3
SCHEMBL7952691 0.85 EGFR (0.55) LMNAGAAMAPTAKR1B1ACP3
SCHEMBL7952698 0.85 EGFR (0.55) LMNAGAAMAPTAKR1B1ACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US claimed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 — — WO claimed
US-6225346-B1 FOR THERAPY AND PROPHYLAXIS OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. 2001-05-01 — — US disclosed
US-5935993-A TYROSINE KINASE INHIBITORS; TREATMENT OF CELL GROWTH, CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1999-08-10 — — US disclosed
US-5891917-A MODULATING TYROSINE SIGNAL TRANSDUCTION TO PREVENT AND TREAT CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS ASSOCIATED WITH PARTICULAR TYROSINE KINASES BY INHIBITING ONE OR MORE ABNORMAL TYROSINE KINASE ACTIVITIES SUGEN, INC. (US) 1999-04-06 — — US disclosed
WO-1996040629-A1 TYRPHOSTIN-LIKE COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS OR CELL DIFFERENTIATION DISORDERS SUGEN, INC. (US) 1996-12-19 — — WO disclosed
Send feedback